Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Chang

Plastic Surgery Fairfax, VA Medical Doctor

NPI 1851558670 CMS profile 1366535

8501 Arlington Blvd, Suite 420, Fairfax, VA 22031

Open in the dashboard

General payments

$13,875

200 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Chang of Fairfax, VA is reported in the CMS Open Payments database as having received $13,875 across 200 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,856 31
2024 General $406 15
2023 General $1,316 24
2022 General $2,349 42
2021 General $1,299 28
2020 General $778 22
2019 General $2,871 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Chang
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Christopher Chang were reported at $4,856. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Christopher Chang Plastic Surgery median Middle half National median
2019 $2,871 $371 $122–$1,483 $163
2020 $778 $158 $52–$438 $114
2021 $1,299 $249 $87–$752 $132
2022 $2,349 $274 $102–$793 $149
2023 $1,316 $299 $113–$891 $160
2024 $406 $361 $124–$1,062 $164
2025 $4,856 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $2,570 47 payments
  2. Motiva USA, LLC $2,531 3 payments
  3. Sientra, Inc. $2,293 41 payments
  4. Allergan Inc. $1,292 49 payments
  5. Medical Device Business Services, Inc. $1,084 5 payments
  6. Integra LifeSciences Corporation $792 6 payments
  7. Galderma Laboratories, L.P. $668 14 payments
  8. Smith+Nephew, Inc. $639 6 payments
  9. Mentor Worldwide LLC $501 6 payments
  10. Tepha Inc $218 2 payments
  11. Other $1,287 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,787 190 payments
  2. Consulting Fee $2,433 1 payment
  3. Travel and Lodging $2,206 8 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $450 1 payment
Products named General payments · program years 2019–2025
  1. Motiva Implant Matrix $2,531 3 payments
  2. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $2,293 41 payments
  3. NATRELLE SALINE-FILLED BREAST IMPLANTS $1,935 15 payments
  4. REVOLVE $1,453 9 payments
  5. ARTOURA Breast Tissue Expander $1,242 8 payments
  6. MemoryGel Breast Implants $1,153 8 payments
  7. CENTERSCOPE Magnetic Detection Device $1,084 5 payments
  8. FlexHD Acellular Hydrated Dermis $1,084 5 payments
  9. BOTOX $797 40 payments
  10. TENOGLIDE $323 3 payments
  11. Other $4,728 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

200 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record